ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

0QNV Addex Therapeutics Ltd

3.02
0.00 (0.00%)
Apr 18 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Addex Therapeutics Ltd 0QNV London Ordinary Share
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 3.02 19:00:00
Open Price Low Price High Price Close Price Previous Close
3.02 3.02
more quote information »

Recent News

Date Time Source Heading
4/19/202400:00UKREGAddex to Present at the Swiss Biotech Day 2024
4/18/202400:00UKREGAddex Therapeutics Reports Full Year 2023 Financial Results..
4/11/202400:00UKREGAddex Therapeutics to Release Full-Year 2023 Financial..
4/03/202400:00UKREGAddex and Perceptive Launch Neurosterix with $63 Million to..
3/14/202401:00UKREGAddex to Present at the Bio-Europe Spring 2024 Conference
1/31/202400:00UKREGAddex Enters into At-The-Market ADS Offering Agreement with..
1/09/202400:00GLOBEAddex to Present at the Swiss Equities Baader Conference
1/05/202400:30GLOBEAddex to Present at Biotech Showcase™ 2024
12/20/202300:00GLOBEAddex Shareholders Approve All Resolutions at Extraordinary..
12/14/202300:00GLOBEAddex Creates Treasury Shares
11/29/202300:00GLOBEAddex Reports Q3 2023 Financial Results and Provides..
11/28/202300:00GLOBEAddex Convenes Extraordinary General Meeting
11/23/202300:00GLOBEAddex Therapeutics to Release Third Quarter 2023 Financial..
11/14/202300:00GLOBEAddex ADX71149 Epilepsy Phase 2 Study Completes Recruitment..
11/08/202300:00GLOBEAddex Regains Nasdaq Listing Compliance
11/02/202301:00GLOBEAddex Announces Participation in the Bio-Europe 2023..
10/20/202300:00GLOBEAddex Completes ADS Ratio Change
10/06/202315:00GLOBEAddex Announces Plan to Implement ADS Ratio Change
9/20/202300:00GLOBEAddex mGlu2 NAM Cognition Program Receives €4 Million Grant
9/06/202300:00GLOBEAddex Announces Participation in the H.C. Wainwright 25th..
9/05/202300:00GLOBEAddex ADX71149 Phase 2 Epilepsy Study Expected to Readout..
9/04/202300:00GLOBEAddex’s Dipraglurant Development in Post-Stroke Recovery..
8/10/202300:00GLOBEAddex Reports 2023 Half Year and Second Quarter Financial..
8/04/202300:00GLOBEAddex Therapeutics to Release Half-Year 2023 Financial..
8/03/202300:00GLOBEAddex GABAB Positive Allosteric Modulator Program to Receive..
7/24/202300:00GLOBEAddex mGlu2PAM Demonstrates Potential in Substance Use..
6/15/202300:00GLOBEAddex Increases Issued Share Capital to Create Treasury..
6/01/202300:00GLOBEAddex Shareholders Approve All Resolutions at Annual General..
5/18/202300:00GLOBEAddex Receives Nasdaq Notification Regarding Minimum Bid..
5/11/202300:00GLOBEAddex Reports Q1 2023 Financial Results and Provides..
5/10/202300:00GLOBEAddex Announces ADX71149 Phase 2 Epilepsy Clinical Study’s..
5/05/202300:00GLOBEAddex Convenes Annual General Meeting 2023
5/04/202300:00GLOBEAddex Therapeutics to Release Q1 2023 Financial Results and..

Your Recent History

Delayed Upgrade Clock